Cite
HARVARD Citation
Kutlar, A. et al. (n.d.). A dose‐escalation phase IIa study of 2, 2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease. American journal of hematology. 88 (11), pp. E255-E260. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kutlar, A. et al. (n.d.). A dose‐escalation phase IIa study of 2, 2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease. American journal of hematology. 88 (11), pp. E255-E260. [Online].